These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 24011429)

  • 1. Non-invasive prenatal screening for trisomy 21: what women want and are willing to pay.
    Verweij EJ; Oepkes D; de Vries M; van den Akker ME; van den Akker ES; de Boer MA
    Patient Educ Couns; 2013 Dec; 93(3):641-5. PubMed ID: 24011429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis.
    Beulen L; Grutters JP; Faas BH; Feenstra I; van Vugt JM; Bekker MN
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():53-61. PubMed ID: 25238658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis.
    Neyt M; Hulstaert F; Gyselaers W
    BMJ Open; 2014 Nov; 4(11):e005922. PubMed ID: 25380810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience of noninvasive prenatal testing with cell-free DNA for fetal trisomies 21, 18, and 13, in a general screening population.
    Fairbrother G; Johnson S; Musci TJ; Song K
    Prenat Diagn; 2013 Jun; 33(6):580-3. PubMed ID: 23494956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population.
    Song K; Musci TJ; Caughey AB
    J Matern Fetal Neonatal Med; 2013 Aug; 26(12):1180-5. PubMed ID: 23356557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis.
    Fairbrother G; Burigo J; Sharon T; Song K
    J Matern Fetal Neonatal Med; 2016; 29(7):1160-4. PubMed ID: 26000626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol.
    Hill M; Wright D; Daley R; Lewis C; McKay F; Mason S; Lench N; Howarth A; Boustred C; Lo K; Plagnol V; Spencer K; Fisher J; Kroese M; Morris S; Chitty LS
    BMC Pregnancy Childbirth; 2014 Jul; 14():229. PubMed ID: 25027965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies.
    O'Leary P; Maxwell S; Murch A; Hendrie D
    Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):425-33. PubMed ID: 24090461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obstetric professionals' perceptions of non-invasive prenatal testing for Down syndrome: clinical usefulness compared with existing tests and ethical implications.
    Ngan OMY; Yi H; Wong SYS; Sahota D; Ahmed S
    BMC Pregnancy Childbirth; 2017 Sep; 17(1):285. PubMed ID: 28870159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new era in prenatal care: non-invasive prenatal testing in Switzerland.
    Manegold-Brauer G; Kang Bellin A; Hahn S; De Geyter C; Buechel J; Hoesli I; Lapaire O
    Swiss Med Wkly; 2014 Feb; 144():w13915. PubMed ID: 24549748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The provision of information and informed decision-making on prenatal screening for Down syndrome: a questionnaire- and register-based survey in a non-selected population.
    Schoonen M; Wildschut H; Essink-Bot ML; Peters I; Steegers E; de Koning H
    Patient Educ Couns; 2012 Jun; 87(3):351-9. PubMed ID: 22030253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals.
    Kater-Kuipers A; Bunnik EM; de Beaufort ID; Galjaard RJH
    BMC Pregnancy Childbirth; 2018 Oct; 18(1):409. PubMed ID: 30340550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Small cost to pay for peace of mind': Women's experiences with non-invasive prenatal testing.
    Bowman-Smart H; Savulescu J; Mand C; Gyngell C; Pertile MD; Lewis S; Delatycki MB
    Aust N Z J Obstet Gynaecol; 2019 Oct; 59(5):649-655. PubMed ID: 30724335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NIPT-based screening for Down syndrome and beyond: what do pregnant women think?
    van Schendel RV; Dondorp WJ; Timmermans DR; van Hugte EJ; de Boer A; Pajkrt E; Lachmeijer AM; Henneman L
    Prenat Diagn; 2015 Jun; 35(6):598-604. PubMed ID: 25693726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal screening for Down syndrome: women's involvement in decision-making and their attitudes to screening.
    Seror V; Ville Y
    Prenat Diagn; 2009 Feb; 29(2):120-8. PubMed ID: 19123253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Women's preference for non-invasive prenatal DNA testing versus chromosomal microarray after screening for Down syndrome: a prospective study.
    Cheng Y; Leung WC; Leung TY; Choy KW; Chiu R; Lo TK; Kwok KY; Sahota DS
    BJOG; 2018 Mar; 125(4):451-459. PubMed ID: 29125674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health economic evaluation of noninvasive prenatal testing and serum screening for down syndrome.
    Xiao G; Zhao Y; Huang W; Hu L; Wang G; Luo H
    PLoS One; 2022; 17(4):e0266718. PubMed ID: 35421148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part II-women's perspectives.
    van Schendel RV; Page-Christiaens GC; Beulen L; Bilardo CM; de Boer MA; Coumans AB; Faas BH; van Langen IM; Lichtenbelt KD; van Maarle MC; Macville MV; Oepkes D; Pajkrt E; Henneman L;
    Prenat Diagn; 2016 Dec; 36(12):1091-1098. PubMed ID: 27739584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of non-invasive prenatal testing: preferences of Canadian pregnant women, their partners, and health professionals regarding NIPT use and access.
    Birko S; Ravitsky V; Dupras C; Le Clerc-Blain J; Lemoine ME; Affdal AO; Haidar H; Laberge AM
    BMC Pregnancy Childbirth; 2019 Jan; 19(1):22. PubMed ID: 30630440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-invasive prenatal testing: challenges for future implementation].
    Henneman L; Page-Chrisiaens GC; Oepkes D
    Ned Tijdschr Geneeskd; 2015; 159():A9479. PubMed ID: 26530119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.